Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant Mortality | 3 | 2026 | 183 | 1.410 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2021 | 222 | 1.210 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2021 | 333 | 1.060 |
Why?
|
| Mass Drug Administration | 1 | 2026 | 14 | 0.940 |
Why?
|
| Azithromycin | 1 | 2026 | 51 | 0.920 |
Why?
|
| Exanthema | 1 | 2024 | 74 | 0.760 |
Why?
|
| Infant, Low Birth Weight | 1 | 2023 | 172 | 0.730 |
Why?
|
| Airway Extubation | 1 | 2023 | 70 | 0.720 |
Why?
|
| Infant, Premature, Diseases | 2 | 2021 | 255 | 0.680 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 80 | 0.660 |
Why?
|
| Perinatal Mortality | 1 | 2020 | 44 | 0.640 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 150 | 0.590 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 177 | 0.570 |
Why?
|
| Infant, Premature | 6 | 2023 | 872 | 0.520 |
Why?
|
| Premature Birth | 1 | 2021 | 428 | 0.500 |
Why?
|
| Infant, Newborn | 10 | 2024 | 8635 | 0.490 |
Why?
|
| Puerperal Infection | 1 | 2015 | 7 | 0.450 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 457 | 0.450 |
Why?
|
| Anti-Bacterial Agents | 2 | 2026 | 2596 | 0.420 |
Why?
|
| Developing Countries | 1 | 2015 | 305 | 0.380 |
Why?
|
| Prenatal Care | 1 | 2015 | 345 | 0.370 |
Why?
|
| Amino Acids | 2 | 2012 | 566 | 0.300 |
Why?
|
| Neonatal Sepsis | 2 | 2020 | 39 | 0.300 |
Why?
|
| Pregnancy | 6 | 2021 | 7512 | 0.290 |
Why?
|
| Infant | 5 | 2026 | 13352 | 0.260 |
Why?
|
| Mali | 1 | 2026 | 13 | 0.240 |
Why?
|
| Vitamin A | 1 | 2013 | 58 | 0.200 |
Why?
|
| Vitamins | 1 | 2013 | 111 | 0.190 |
Why?
|
| Humans | 13 | 2026 | 131163 | 0.190 |
Why?
|
| Vascular Malformations | 1 | 2024 | 103 | 0.190 |
Why?
|
| Sirolimus | 1 | 2024 | 230 | 0.180 |
Why?
|
| Sheep | 1 | 2012 | 229 | 0.170 |
Why?
|
| Pancreas | 1 | 2012 | 217 | 0.170 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 133 | 0.170 |
Why?
|
| Birth Weight | 1 | 2023 | 347 | 0.170 |
Why?
|
| Glucose | 2 | 2012 | 853 | 0.170 |
Why?
|
| Indomethacin | 1 | 2021 | 79 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2013 | 247 | 0.170 |
Why?
|
| Leucine | 1 | 2012 | 259 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2026 | 1267 | 0.160 |
Why?
|
| Nitric Oxide | 1 | 2013 | 471 | 0.160 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2020 | 361 | 0.160 |
Why?
|
| Dietary Supplements | 1 | 2013 | 448 | 0.160 |
Why?
|
| Dexamethasone | 1 | 2021 | 250 | 0.160 |
Why?
|
| Morbidity | 1 | 2021 | 256 | 0.160 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2019 | 41 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2020 | 164 | 0.150 |
Why?
|
| Malawi | 1 | 2020 | 348 | 0.150 |
Why?
|
| Machine Learning | 1 | 2023 | 387 | 0.150 |
Why?
|
| Fetus | 1 | 2012 | 568 | 0.140 |
Why?
|
| Insulin | 1 | 2012 | 1149 | 0.130 |
Why?
|
| Gestational Age | 1 | 2021 | 1224 | 0.120 |
Why?
|
| Female | 8 | 2021 | 70963 | 0.120 |
Why?
|
| Sepsis | 1 | 2020 | 493 | 0.120 |
Why?
|
| Organ Size | 2 | 2012 | 407 | 0.090 |
Why?
|
| Infusions, Intravenous | 2 | 2012 | 531 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17753 | 0.070 |
Why?
|
| Risk Factors | 1 | 2020 | 11074 | 0.060 |
Why?
|
| Early Medical Intervention | 1 | 2013 | 32 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2013 | 238 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 193 | 0.050 |
Why?
|
| Animals, Inbred Strains | 1 | 2012 | 5 | 0.050 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2012 | 5 | 0.050 |
Why?
|
| Sheep, Domestic | 1 | 2012 | 17 | 0.050 |
Why?
|
| Solutions | 1 | 2012 | 50 | 0.050 |
Why?
|
| Electrolytes | 1 | 2012 | 59 | 0.050 |
Why?
|
| Glucagon | 1 | 2012 | 146 | 0.050 |
Why?
|
| Fetal Weight | 1 | 2012 | 64 | 0.050 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2012 | 5 | 0.050 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2012 | 17 | 0.050 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2012 | 75 | 0.050 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2012 | 32 | 0.050 |
Why?
|
| Acid-Base Equilibrium | 1 | 2012 | 60 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2012 | 86 | 0.040 |
Why?
|
| Random Allocation | 1 | 2012 | 409 | 0.040 |
Why?
|
| Risk | 1 | 2013 | 726 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2012 | 358 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2012 | 149 | 0.040 |
Why?
|
| Hormones | 1 | 2012 | 162 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 436 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 270 | 0.040 |
Why?
|
| Male | 3 | 2020 | 64957 | 0.040 |
Why?
|
| Child | 1 | 2021 | 26341 | 0.040 |
Why?
|
| Arginine | 1 | 2012 | 340 | 0.040 |
Why?
|
| Kinetics | 1 | 2012 | 1088 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2012 | 1013 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 526 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 263 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2012 | 690 | 0.030 |
Why?
|
| Incidence | 1 | 2013 | 3360 | 0.030 |
Why?
|
| Animals | 2 | 2012 | 33912 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3686 | 0.020 |
Why?
|